Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
Resumen: Background: Hopelessness is a risk factor for depression and suicide. There is little information on this phenomenon among patients with relapsing-remitting multiple sclerosis (RRMS), one of the most common causes of disability and loss of autonomy in young adults. The aim of this study was to assess state hopelessness and its associated factors in early-stage RRMS.
Methods: A multicenter, non-interventional study was conducted. Adult patients with a diagnosis of RRMS, a disease duration ≤ 3 years, and an Expanded Disability Status Scale (EDSS) score of 0– 5.5 were included. The State-Trait Hopelessness Scale (STHS) was used to measure patients´ hopelessness. A battery of patient-reported and clinician-rated measurements was used to assess clinical status. A multivariate logistic regression analysis was conducted to determine the association between patients’ characteristics and state hopelessness.
Results: A total of 189 patients were included. Mean age (standard deviation-SD) was 36.1 (9.4) years and 71.4% were female. Median disease duration (interquartile range-IQR) was 1.4 (0.7, 2.1) years. Symptom severity and disability were low with a median EDSS (IQR) score of 1.0 (0, 2.0). A proportion of 65.6% (n=124) of patients reported moderate-to-severe hopelessness. Hopelessness was associated with older age (p=0.035), depressive symptoms (p=< 0.001), a threatening illness perception (p=0.001), and psychological and cognitive barriers to workplace performance (p=0.029) in the multivariate analysis after adjustment for confounders.
Conclusion: Hopelessness was a common phenomenon in early-stage RRMS, even in a population with low physical disability. Identifying factors associated with hopelessness may be critical for implementing preventive strategies helping patients to adapt to the new situation and cope with the disease in the long term.

Idioma: Inglés
DOI: 10.2147/PPA.S411069
Año: 2023
Publicado en: PATIENT PREFERENCE AND ADHERENCE 17 (2023), 1431-1439
ISSN: 1177-889X

Factor impacto JCR: 2.0 (2023)
Categ. JCR: MEDICINE, GENERAL & INTERNAL rank: 102 / 329 = 0.31 (2023) - Q2 - T1
Factor impacto CITESCORE: 3.6 - Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1) - Social Sciences (miscellaneous) (Q1) - Health Policy (Q2) - Medicine (miscellaneous) (Q2)

Factor impacto SCIMAGO: 0.647 - Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1) - Social Sciences (miscellaneous) (Q1) - Health Policy (Q2) - Medicine (miscellaneous) (Q2)

Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial.


Exportado de SIDERAL (2024-11-22-12:02:30)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos > Artículos por área > Medicina



 Registro creado el 2024-02-19, última modificación el 2024-11-25


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)